US/UK/Canada

Share

Contacts

  • Inga-Lill Carlberg

    Chief Operating Officer


    Sveavägen 9, 111 57 Stockholm
    +46733-577010
    https://www.trillimpact.com

    • Links

    Pick a time period -
    Tags ( Active)

    Trading in Trill Impact’s portfolio company Cinclus Pharma commences on Nasdaq Stockholm

    The Swedish biopharmaceutical company has successfully raised capital for Phase 3 clinical developmentCinclus Pharma Holding AB (publ) (“Cinclus Pharma”) is a Swedish late-stage pharmaceutical company committed to improving the medical outcomes for patients suffering from severe stomach acid-related disorders worldwide. The company is targeting two main clinical indications; GERD (Gastroesophageal reflux disease) and H. pylori infection. Cinclus Pharmas’ drug candidate, linaprazan glurate, is a proprietary prodrug of the molecule linaprazan, originally developed by AstraZeneca.

    Trill Impact Ventures co-leads USD 25 million series B financing round in May Health

    Advancing novel treatment for women suffering from Polycystic Ovary Syndrome related infertility.Trill Impact Ventures, announces that it together with Bpifrance, has co-led a USD 25m series B financing round in May Health, a French-American medical device company targeting Polycystic Ovary Syndrome (PCOS) related infertility. The round also saw participation from existing May Health investor Sofinnova Partners. Proceeds will advance the clinical development of May Health’s innovative device, as well as reaching CE marking that will enable market introduction in select European countries.

    Trill Impact Ventures co-leads the USD 50m financing round in Open Cosmos Ltd.

    Multi-sensor satellites and data analytics to support achievement of the SDGs and democratize access to space data.SEPTEMBER 11, 2023Trill Impact Ventures, Trill Impact’s venture capital strategy, announces that it has co-led the USD 50m (EUR 46m) financing round in Open Cosmos, a leading space tech company that collects and analyzes satellite data to solve pressing global challenges such as climate change, humanitarian disasters, and resource management. Other co-lead investors participating in the round include ETF Partners and A&G's Energy Transition Tech Fund. Proceeds from the round

    Trill Impact to build a cybersecurity leader to improve resilience against cybercrime

    With an ambition to build a leading group that addresses the increasing need for cybersecurity services, Trill Impact has closed investments in Arctic Group AB (“Arctic Group”) and ID North AB (“ID North”) to form a strong platform for future expansion, jointly called European ID Security (“the Group”).In today’s world of digital transformation, the IT security of governments and enterprises is at risk, with identity theft, data breaches and insider threats among the top ten cyberthreats in the European Union. These are serious security concerns which have been further amplified during the

    There are no items matching the current filter
    There are no more items matching the current filter
    Back to top

    Subscribe

    Media